AffiNANOTECH® Cantuzumab mertansine
CAT# AFG-MCX-0370
Size: 1 mg
Availables Sizes: 1 mg, 5 mg.
Overview
Cantuzumab mertansine (SB-408075; huC242-DM1), anADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward coloncancercells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.
Isotype
N/A.
Species
N/A.
Target
N/A.
Appearance
N/A.
Shipping Conditions
N/A.
Storage Conditions
Store the product under the recommended conditions in the Certificate of Analysis.